Distinct molecular subtypes of breast cancer have been identified using the presence or absence of biomarkers, including estrogen receptors (ER+/ER-), progesterone receptors (PR+/PR-), and human epidermal growth factor 2 (HER2+/HER2-) [6–8]. Here, ERBB2 is linked to breast cancer.